IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q1 2019 Holdings

Filed 2019-05-15 | 3 holdings | $5.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Onconova Therapeutics IncCOM NEW68232V405$2.7K816,27253.3%
MMA Cap Mgmt LLC(MMAC)COM55315D105$2.3K75,55245.3%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$74390,6241.5%